Follow
Pedro M. Costa
Pedro M. Costa
Institute of Pharmaceutical Science, King's College London
Verified email at kcl.ac.uk
Title
Cited by
Cited by
Year
MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma
PM Costa, AL Cardoso, C Custódia, P Cunha, LP de Almeida, ...
Journal of Controlled Release 207, 31-39, 2015
1902015
Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo
H Kafa, JTW Wang, N Rubio, R Klippstein, PM Costa, HAFM Hassan, ...
Journal of Controlled Release 225, 217-229, 2016
1192016
Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatment
PM Costa, AL Cardoso, LS Mendonça, A Serani, C Custódia, ...
Molecular Therapy-Nucleic Acids 2, 2013
1162013
Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype
M Conceição, L Mendonça, C Nóbrega, C Gomes, P Costa, H Hirai, ...
Biomaterials 82, 124-137, 2016
992016
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
PM Costa, AL Cardoso, C Nobrega, LF Pereira de Almeida, JN Bruce, ...
Human molecular genetics 22 (5), 904-918, 2013
942013
MicroRNAs as molecular targets for cancer therapy: on the modulation of microRNA expression
PM Costa, MC Pedroso de Lima
Pharmaceuticals 6 (10), 1195-1220, 2013
912013
Tf-lipoplex-mediated c-Jun silencing improves neuronal survival following excitotoxic damage in vivo
ALC Cardoso, P Costa, LP De Almeida, S Simoes, N Plesnila, C Culmsee, ...
Journal of Controlled Release 142 (3), 392-403, 2010
552010
Synthesis of double-clickable functionalised graphene oxide for biological applications
KC Mei, N Rubio, PM Costa, H Kafa, V Abbate, F Festy, SS Bansal, ...
Chemical communications 51 (81), 14981-14984, 2015
502015
MicroRNAs in glioblastoma: role in pathogenesis and opportunities for targeted therapies
P M Costa, A L Cardoso, M Mano, M C Pedroso de Lima
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2015
432015
Solvent-free click-mechanochemistry for the preparation of cancer cell targeting graphene oxide
N Rubio, KC Mei, R Klippstein, PM Costa, N Hodgins, JTW Wang, F Festy, ...
ACS applied materials & interfaces 7 (34), 18920-18923, 2015
362015
Organic solvent-free, one-step engineering of graphene-based magnetic-responsive hybrids using design of experiment-driven mechanochemistry
KC Mei, Y Guo, J Bai, PM Costa, H Kafa, A Protti, RC Hider, KT Al-Jamal
ACS applied materials & interfaces 7 (26), 14176-14181, 2015
362015
PDGF-B-mediated downregulation of miR-21: new insights into PDGF signaling in glioblastoma
PM Costa, AL Cardoso, LF Pereira de Almeida, JN Bruce, P Canoll, ...
Human molecular genetics 21 (23), 5118-5130, 2012
302012
Safety profile of the intravenous administration of brain-targeted stable nucleic acid lipid particles
M Conceição, L Mendonça, C Nóbrega, C Gomes, P Costa, H Hirai, ...
Data in brief 6, 700-705, 2016
122016
Viral and non-viral gene therapy for glioblastoma: new insights into the treatment of malignant brain tumors
PM Costa, MCP de Lima
J Genet Syndr Gene Ther 4 (7), 161, 2013
62013
MicroRNA modulation renders glioblastoma cells sensitive to chemotherapy
PP Cunha, P Costa, R Costa, C Custodia, R Branco, CM Morais, ...
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 45, 72-73, 2015
2015
MIR-21 AND MIR-128 DEREGULATION IN GLIOBLASTOMA: EFFECT OF MIRNA MODULATION ON CELL VIABILITY
P Costa, ALC Cardoso, LP de Almeida, MC de Lima, P Canoll, J Bruce
NEURO-ONCOLOGY 12, 9-10, 2010
2010
Tf-lipoplex-mediated c-Jun knockdown results in neuroprotection following excitotoxic injury in the mouse brain
A Cardoso, P Costa, S Simoes, L Almeida, N Plesnila, C Culmsee, ...
HUMAN GENE THERAPY 19 (10), 1127-1128, 2008
2008
The system can't perform the operation now. Try again later.
Articles 1–17